BioQ Pharma

BioQ Pharma is a late stage specialty pharmaceutical company focused on developing and commercializing a portfolio of large volume ready-to-use infusible pharmaceuticals. Our vision is to set a new standard of care in the presentation and administration of infusible pharmaceuticals via our proprietary unit-dose infusion systems that can be deployed quickly and conveniently at the point of care with one touch. Our infusion platform is intended to address some of the most pressing unmet needs in infusion today: cost, medication error, sterility, efficiency, and patient quality of life. BioQ Pharma’s pre-filled infusion systems are applicable to the majority of infusible drugs, spanning post-operative pain management, anesthesia/sedation, chemotherapy, anti-infectives, and biologics. We are focused on the untapped opportunity in unit-dose large volume parenteral drugs. Our ready-to-use infusion pharmaceuticals are intended to provide safety, sterility, value, and convenience. Our value proposition to providers, payors, and patients includes reducing the potential for medication errors, increasing efficiencies by streamlining logistics, and reducing the number of hands that touch the drug en route, thereby enhancing safety and reducing the total cost of drug delivery. We utilize a de-risked commercialization strategy in which BioQ Pharma is the innovator and manager of its network of manufacturing partners to supply finished product to leading pharmaceutical companies for sale under their private label.
Type
Private
HQ
San Francisco, US

Key People at BioQ Pharma

Joshua Kriesel

Joshua Kriesel

CEO

BioQ Pharma Locations

San Francisco, US

BioQ Pharma Metrics

BioQ Pharma Summary

Total Funding

$12.2 M

Latest funding size

$12.2 M

Time since last funding

12 months

Investors

BioQ Pharma News

BioQ Pharma Company Life

You may also be interested in